es sieht nicht gut aus:
MorphoSys AG (NASDAQ:MOR) – Equities researchers at SVB Leerink reduced their Q1 2021 EPS estimates for MorphoSys in a research report issued on Tuesday, March 23rd. SVB Leerink analyst G. Porges now forecasts that the company will earn ($0.54) per share for the quarter, down from their previous forecast of ($0.52). SVB Leerink has a “Market Perform” rating on the stock. SVB Leerink also issued estimates for MorphoSys’ Q2 2021 earnings at ($0.66) EPS, Q3 2021 earnings at ($0.69) EPS, Q4 2021 earnings at ($0.65) EPS, FY2021 earnings at ($2.54) EPS, FY2022 earnings at ($1.58) EPS and FY2024 earnings at $0.90 EPS.